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Abstract 
Background: We assessed the impact of a family history of diabetes on type 2 diabetes, metabolic syndrome, and 
behavioral traits in young Korean adults.
Methods: Subjects aged 25–44 years were included, and the presence of a family history of diabetes was obtained 
by a self-reported questionnaire (the Korea National Health and Nutrition Survey 2010). We compared the prevalence 
of type 2 diabetes and metabolic syndrome, and other metabolic parameters, including blood pressure and lipid 
profile.
Results: Of 2059 participants, those with a family history of diabetes involving first-degree relatives (n = 489, 23.7%) 
had a significantly higher prevalence of impaired fasting glucose (14.3 vs. 11.7%) and type 2 diabetes (6.7 vs. 1.8%), 
compared to those without a family history (P < 0.001). The prevalence of metabolic syndrome (21.3 vs. 12.1%, 
P < 0.001) and its components (except for high-density lipoprotein cholesterol) were greater in subjects with a family 
history of diabetes. Among subjects exhibiting normal glucose tolerance (n = 1704), those with a family history of 
diabetes had higher fasting glucose (89.0 vs. 87.8 mg/dL, P < 0.001) and triglyceride (100.5 vs. 89.0 mg/dL, P < 0.001), 
and lower beta cell function by the homeostasis model assessment (HOMA-β; 134.2 vs. 137.5, P = 0.020). The obesity 
indices (body mass index, waist circumference, and triglyceride) were significantly correlated with those of both par-
ents (P < 0.01 for all variables). Risk-reducing behavior, including regular exercise (18.2 vs. 19.7%, P = 0.469) and calorie 
intake (2174.8 vs. 2149.1 kcal/day, P = 0.636), did not markedly differ according to a family history of diabetes.
Conclusions: Young adults with a family history of diabetes had an increased risk of type 2 diabetes and meta-
bolic syndrome, even though they currently exhibited a normal glycemic profile. Proactive lifestyle consultation is 
requested especially among healthy young population with a family history of diabetes.
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Background
The prevalence of diabetes has increased worldwide dur-
ing recent decades [1, 2]. The global estimate of people 
with diabetes is expected to increase to 592 million by 
2035 [2]; however, a high proportion of individuals with 
diabetes (up to 174.8 million) remain undiagnosed [3]. 
It is clinically important to identify individuals at risk of 
diabetes and metabolic disorders to prevent long-term 
complications and to reduce the socioeconomic burden 
of diabetes.
Young adults with metabolic risk factors such as 




*Correspondence:  drshchoi@snu.ac.kr 
†Joon Ho Moon and Eun Roh contributed equally to this work 
4 Department of Internal Medicine, Seoul National University Bundang 
Hospital, 82, Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam, 
Gyeonggi-do 463-707, South Korea
Full list of author information is available at the end of the article
Page 2 of 9Moon et al. Diabetol Metab Syndr  (2017) 9:16 
regarding the potential for future development of chronic 
metabolic diseases. The early detection of such young 
adults with a future risk of metabolic disorders is vital, 
as the progression to diabetes become irreversible after 
a certain stage [4]. The clinical practice guidelines of the 
American Diabetes Association recommend that dia-
betes screening should be initiated at 45  years of age, 
particularly among individuals who are overweight [5]; 
hence, young adults (those aged  <45  years) were disre-
garded from these screening programs. Nevertheless, we 
believe that young adults should be stratified according 
to their risk of future diabetes, and the high-risk popula-
tion should undergo regular screening.
The development of diabetes mellitus is based on mul-
tiple factors. In particular, the assessment of the family 
history is an inexpensive and useful tool that can reflect 
both the genetic and environmental factors shared by 
families [6]. In fact, a family history of diabetes is found 
to be associated with both cases of insulin secretory 
defect [7] and insulin resistance [8]. According to pre-
vious studies conducted among Caucasians, the inci-
dence of type 2 diabetes was increased by 1.4- to 6.1-fold 
among individuals with a family history of diabetes [6, 
9–11]. Although the increased metabolic risk of hav-
ing a family history of diabetes is expected to be similar 
among Asians, its attributable risk might vary due to dif-
ferent genetic and environmental background [12]. In 
a cross-sectional study of 46,239 middle-aged Chinese 
men and women (mean age, 44.9  years), the familial 
risk of diabetes exhibited a graded association with the 
prevalence of diabetes (6.16-fold higher prevalence if two 
generations of first-degree relatives have diabetes, and 
2.86-fold if one generation of first-degree relatives have 
diabetes) [13]. Middle-aged Japanese men and women 
(mean age 46.2  years) had 1.8-fold increase in incident 
diabetes among whom had a family history of diabetes 
in a 7-year follow-up study [14]. In Korea, some studies 
have described the odds ratio (ORs) for type 2 diabetes 
in middle-aged individuals with a family history of dia-
betes (i.e. OR  =  2.59 in a study by Kim et  al. [15] and 
OR = 1.86 by Lee et al. [16]); however, family history was 
assessed only as a component of multiple risk factors. To 
conclude, studies conducted among Asian population 
revealed similarly increased risk of diabetes than non-
Asians among subjects with a family history of diabetes, 
but none of these studies particularly focused on young 
adults who should be meticulously evaluated for future 
risk of metabolic disease.
In the present study, we aimed to (1) evaluate the 
family history of diabetes as an independent risk fac-
tor for type 2 diabetes and metabolic syndrome; (2) 
compare the metabolic parameters according to family 
history in young adults with currently normal glucose 
levels; (3) identify the metabolic parameters that are 
most likely to be inherited to offspring; and (4) assess 
the metabolic risk-reducing behaviors by presence of a 
family history of diabetes, among young Korean adults 
by using nationwide representative survey data.
Methods
Data source and study population
The data analyzed in the present study were obtained 
from the Korea National Health and Nutrition Survey 
(KNHANES) V (2010). The KNHANES is a nationwide 
community-based cross-sectional survey that exam-
ined the general health and nutritional status of non-
institutionalized civilians in Korea. The KNHANES 
comprised 3 distinct surveys: health interview survey, 
health examination survey, and nutrition survey. Partic-
ipants were selected from sampling units based on the 
geographical area, sex, and age groups. The KNHANES 
was conducted according to the guidelines specified in 
the Declaration of Helsinki. The Institutional Review 
Board of the Korean Centers for Disease Control and 
Prevention approved the study protocol (IRB number: 
2010-02CON-21-C).
Subjects who were aged 25–44  years and completed 
the health interview and examination survey were eligi-
ble for the current analysis (n =  2218). We limited our 
study population to age  <45 to evaluate the metabolic 
risk of a family history of diabetes among young adults 
who are usually not indicated for diabetes screening [12]. 
To minimize the number of subjects with potential type 1 
diabetes in the study population, we set a lower age cutoff 
of 25 years, after which the incidence of type 1 diabetes is 
shown to clearly decrease [17]. Subjects who were diag-
nosed with diabetes prior to 25 years of age or those who 
had started insulin treatment within 1  year of diabetes 
diagnosis were also excluded (n = 2). Moreover, subjects 
with pregnancy, cancer (except thyroid cancer), and ster-
oid medication were excluded for the analysis (n = 159). 
A subgroup of the subjects’ parents participated in the 
KNHANES (n  =  578, 28.1%); these individuals were 
administered the same survey.
Definition of family history
A family history of diabetes involving first-degree rela-
tives (parents and siblings) was recorded via the self-
reported questionnaire in the health interview survey. 
By utilizing parents’ self-report as the standard, the esti-
mated sensitivity, specificity, and accuracy of proband-
reported family history in this study was 84.3, 97.0, and 
95.2%. The validity of family history was generally in 
accordance with previous studies [18–21].
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Definition of type 2 diabetes and metabolic syndrome
The primary outcome of the study was the prevalence of 
type 2 diabetes and metabolic syndrome by a family his-
tory of diabetes. Diagnosis of diabetes, impaired fasting 
glucose (IFG), and normal glucose tolerance (NGT) were 
based on the American Diabetes Association guidelines 
[5]. Abnormal glucose tolerance (AGT) was considered 
in cases with either IFG or diabetes. Metabolic syndrome 
was diagnosed if ≥3 of the criteria were met, according 
to the National Cholesterol Education Program (NCEP) 
Adult Treatment panel (ATP) III revised criteria [22]. 
Central obesity was defined as waist circumference 
(WC) >90 cm in men and >80 cm in women, based on the 
International Obesity Task Force criteria for the Asian–
Pacific population [23]. Metabolically healthy status was 
either defined by (1) the absence of metabolic syndrome 
(<3 components of metabolic syndrome) [24], or (2) high 
insulin sensitivity [defined by homeostasis model assess-
ment of insulin resistance (HOMA-IR) <2.5] [25].
Anthropometric and biochemical assessments
Height and WC was measured to the nearest 0.1 cm and 
weight was measured to the nearest 0.1 kg. Blood pres-
sure was measured twice with a mercury sphygmoma-
nometer (Baumanometer, Baum, Copiague, NY, U.S.A.), 
with the patient in the sitting position after a 10-min rest. 
An averaged value of these measurements was used for 
the analysis.
Blood samples were drawn from the antecubital vein 
in the morning after fasting for at least 8  h. The fast-
ing plasma concentrations of glucose, total cholesterol, 
triglyceride, high-density lipoprotein (HDL) choles-
terol, aspartate transaminase, alanine transaminase, 
and gamma-glutamyl transpeptidase were measured 
enzymatically using an autoanalyzer (Hitachi 7600, 
Hitachi, Tokyo, Japan). Insulin was measured by immu-
noradiometric assay (1470 WIZARD gamma-Counter, 
PerkinElmer, Turku, Finland). Glycated hemoglobin 
was measured by high-performance liquid chromatog-
raphy (HLC-723G7, Tosoh, Tokyo, Japan). The HOMA 
value of insulin resistance (HOMA-IR) and β-cell func-
tion (HOMA-β) were also calculated [26]. The level of 
low-density lipoprotein (LDL) cholesterol was calculated 
using Friedewald’s formula [27].
Exercise and diet
Physical activity data were collected from the self-admin-
istered questionnaire; physical activity was classified as 
mild, moderate, or vigorous [28]. Regular exercise was 
defined as moderate intensity activity for >30 min, for 5 
times a week, or vigorous intensity activity for >20 min, 
for 3 times a week. Dietary data were collected using 
the food intake questionnaire, which is an open-ended 
survey for reporting food consumption via the 24-h recall 
method [29].
Statistical analysis
Data are presented as number (%), mean  ±  standard 
deviation for the variables in a Gaussian distribution, or 
as median (interquartile range) for the other variables. 
The χ2 test was used for comparing categorical vari-
ables. ORs were estimated with their corresponding 95% 
confidence intervals (CIs), as well as P values, to evalu-
ate the risk of type 2 diabetes and metabolic syndrome 
according to the family history of diabetes. Sensitivity 
analysis according to body mass index (BMI) (normal 
weight: BMI < 23 kg/m2, overweight: 23 ≤ BMI < 25 kg/
m2, obese: BMI  ≥  25  kg/m2) was performed. Statisti-
cal differences between the groups were examined using 
Student’s t test or analysis of variance (ANOVA) for con-
tinuous variables. Variables with a skewed distribution 
were log-transformed for analyses. Variables that showed 
significant association with a family history of diabetes 
were further adjusted for age and BMI. Correlation anal-
ysis was conducted for BMI, WC, fasting plasma glucose 
(FPG), triglyceride, HOMA-IR, and HOMA-β between 
the parents and offspring. Statistical significance was 
defined as a P value of <0.05. All statistical analyses were 




A total of 2059 subjects (876 men and 1183 women) aged 
25–44  years were included in the analysis. The baseline 
characteristics of all study participants according to the 
glycemic status are described in Additional file  1: Table 
S1. The mean age was 35.5 ±  5.4  years and mean BMI 
was 23.4 ±  3.6  kg/m2. Of these, 1744 (84.7%) exhibited 
NGT, 254 exhibited IFG (12.3%), and 61 (3.0%) exhib-
ited type 2 diabetes. The men had a higher prevalence of 
AGT (21.2%, 185 subjects) than the women (11.0%, 130 
subjects) (P < 0.001). Subjects with IFG or type 2 diabetes 
exhibited adverse metabolic parameters, including BMI, 
blood pressure, FPG concentration, lipid profile, HOMA-
IR, and HOMA-β in both genders, compared to those 
with NGT.
Of all the subjects, 489 (23.7%) had at least 1 first-
degree relative with diabetes (men, 221 [25.2%]; women, 
268 [22.7%]). Among these subjects, 476 (23.1%) had at 
least one parent with diabetes, including 255 (12.4%) 
who had a father with diabetes, 173 (8.4%) who had 
a mother with diabetes, and 48 (2.3%) who had both 
parents with diabetes. Forty subjects (1.9%) had a sib-
ling with diabetes. A total of 421 (20.4%) had 1 family 
member with diabetes, 61 (3.0%) had 2 family members 
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with diabetes, and 7 (0.3%) had 3 family members with 
diabetes.
Glycemic status and prevalence of metabolic syndrome 
according to the family history of diabetes
We then evaluated the glycemic status and prevalence 
of metabolic syndrome according to the family history 
of diabetes involving first-degree relatives. Among 489 
subjects with a family history of diabetes, 386 (78.9%) 
exhibited NGT, 70 (14.3%) exhibited IFG, and 33 (6.7%) 
exhibited type 2 diabetes, with increasing trend com-
pared to those without a family history of diabetes (P-for-
trend <0.001) (Table 1). The OR for IFG among subjects 
with a family history of diabetes was 1.34 (95% CI 1.00–
1.80), whereas that for type 2 diabetes among subjects 
with a family history of diabetes was 4.14 (95% CI 2.47–
6.95) (Fig. 1a).
We also assessed the association between metabolic 
syndrome and the family history of diabetes. The prev-
alence of metabolic syndrome was 21.3% (n  =  104 of 
489) among subjects with a family history of diabetes, 
which was significantly higher than 12.1% (n  =  190 of 
1570) among subjects without a family history of dia-
betes (P  <  0.001). Each component of metabolic syn-
drome, except for HDL level, showed higher prevalence 
in subjects with a family history of diabetes (Fig. 1b). We 
further analyzed metabolically healthy status (<3 com-
ponents of metabolic syndrome) in combination with 
obesity [24]. Subjects with a family history of diabetes 
tend to have lower proportion of metabolically healthy 
non-obese, but higher proportion of metabolically 
unhealthy non-obese and metabolically unhealthy obese 
Table 1 Glycemic status and  prevalence of  metabolic syndrome according to  family history of  diabetes in  first-degree 
relatives
Statistical significance was defined as a P value of <0.05 (Italic values)
FH family history of diabetes, IFG impaired fasting glucose, NGT normal glucose tolerance
P values are from χ2-test
Total (n = 2059) Men (n = 876) Women (n = 1183)
FH− FH+ P FH− FH+  P FH− FH+ P
(n = 1570) (n = 489) (n = 655) (n = 221) (n = 915) (n = 268)
Glycemic status
NGT 1358 (86.5%) 386 (78.9%) <0.001 533 (81.4%) 158 (71.5%) <0.001 825 (90.2%) 228 (85.1%) 0.019
IFG 184 (11.7%) 70 (14.3%) 111 (16.9%) 42 (19.0%) 73 (8.0%) 28 (10.4%)
Diabetes 28 (1.8%) 33 (6.7%) 11 (1.7%) 21 (9.5%) 17 (1.9%) 12 (4.5%)
Prevalence of metabolic syndrome 190 (12.1%) 104 (21.3%) <0.001 123 (18.8%) 74 (33.5%) <0.001 67 (7.3%) 30 (11.2%) 0.042
Waist circumference (>90 cm in men 
and >80 cm in women)
344 (22.1%) 131 (26.9%) 0.029 144 (22.1%) 58 (26.5%) 0.186 200 (22.1%) 73 (27.2%) 0.082
Triglycerides (≥150 mg/dL or medication 
use)
323 (20.6%) 146 (29.9%) <0.001 236 (36.1%) 105 (47.5%) 0.003 87 (9.5%) 41 (15.3%) 0.010
HDL cholesterol (<40 mg/dL in men 
and <50 mg/dL in women or medication 
use)
583 (37.2%) 200 (40.9%) 0.142 205 (31.3%) 83 (37.6%) 0.089 378 (41.4%) 117 (43.7%) 0.511
Blood pressure (≥130/85 mmHg or antihy-
pertensive medication use)
222 (14.1%) 100 (20.4%) 0.001 162 (24.7%) 83 (37.6%) <0.001 60 (6.6%) 17 (6.3%) 0.901
Fasting glucose (≥100 mg/dL or medica-
tion use)
212 (13.5%) 103 (21.1%) <0.001 122 (18.6%) 63 (28.5%) 0.002 90 (9.8%) 40 (14.9%) 0.019
Fig. 1 Odds ratios for type 2 diabetes and metabolic syndrome in 
subjects with family history of diabetes. Risks for impaired fasting glu-
cose, type 2 diabetes (a), metabolic syndrome and each component 
(b) in subjects with family history of diabetes in first-degree relatives 
are presented by odds ratio. Criteria for metabolic syndrome followed 
NCEP-ATP III revised criteria. *P < 0.05
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(Additional file 1: Table S2). The degree of insulin sensi-
tivity is also a frequently used measure to define meta-
bolically healthy status [25]. A total of 40.3% of subjects 
with a family history of diabetes had insulin resistance 
(defined by HOMA-IR ≥2.5), whereas 31.0% of subjects 
without a family history of diabetes had insulin resist-
ance (HOMA-IR; 2.60 ± 1.49 vs. 2.34 ± 1.30, P = 0.001) 
(Additional file 1: Table S2).
We performed stratified analysis according to BMI sta-
tus, as obesity may contribute to increased risk of meta-
bolic disease in subjects with family history of diabetes. 
In fact, subjects with a family history had higher BMI 
subjects without a family history of diabetes (23.7 ± 3.6 
vs. 23.1  ±  3.5  kg/m2, P  =  0.001). In each BMI group, 
subjects with a family history had higher prevalence of 
AGT (either IFG or diabetes) and metabolic syndrome 
compared to subjects without family history (Additional 
file  1: Table S3); only exception in AGT of overweight 
group did not reach statistical significance (P =  0.107). 
To conclude, an increased risk of metabolic disease in 
subjects with a family history of diabetes was consistent 
in different BMI groups.
Metabolic profiles of young adults with NGT according 
to the family history of diabetes
We evaluated the metabolic parameters among young 
adults with currently normal glucose tolerance but had a 
family history of diabetes (Table 2). We initially adjusted 
for age, as the subjects with a family history of diabetes 
were older. Subjects with a family history of diabetes had 
higher BMI, diastolic blood pressure, total cholesterol, 
triglyceride, and FPG, and lower HOMA-β. After fur-
ther adjustment for BMI, triglyceride and FPG remained 
higher, and HOMA-β remained lower in subjects with a 
family history of diabetes. A similar trend was observed 
when IFG subjects were included in the analysis; in fact, 
the triglyceride and FPG levels were still higher in sub-
jects with a family history of diabetes after these adjust-
ments (Additional file 1: Table S4).
Number of family members with diabetes and adverse 
metabolic outcome
We then evaluated whether the number of family mem-
bers with diabetes affected the prevalence of AGT and 
metabolic syndrome (Additional file  1: Table S5). The 
prevalence of AGT was higher when they had more fam-
ily members with diabetes. A total of 13.5% of subjects 
without a family history of diabetes had AGT, whereas 
20.4% of subjects with 1 family member with diabetes 
and 25.0% of subjects with ≥2 family members with dia-
betes, had AGT. The prevalence of metabolic syndrome 
also increased as the number of family members with 
diabetes increased (no family history of diabetes, 12.0%; 1 
family member with diabetes, 19.7%; ≥2 family members 
with diabetes, 27.9%).
Correlation of metabolic parameters between parents 
and offspring
To identify the metabolic parameters that were inherited 
or had a strong correlation with those of their parents, 
we compared the BMI, WC, FPG, triglyceride levels, 
HOMA-IR, and HOMA-β between parents and their 
offspring via a correlation analysis (Table  3). The BMI, 
WC, and triglyceride concentration of the participants 
were significantly correlated with those of both parents, 
whereas the FPG concentration and HOMA-β were only 
correlated with those of the mother.
Risk‑reducing behavior and diabetes status according 
to family history of diabetes
We analyzed the risk-reducing behavior and diabe-
tes status in subjects with a family history of diabetes 
(Additional file 1: Table S6). The proportion of subjects 
who performed regular exercise (with vs. without a fam-
ily history of diabetes; 18.2% vs. 19.7%) and those who 
attempted to lose weight (73.0 vs. 74.5%) did not differ 
according to the family history of diabetes. The total 
energy intake (2175.8 vs. 2149.1  kcal) and macronutri-
ent consumption were similar between the two groups. 
Among the subjects with diabetes (n = 61), the diabetes 
recognition rate (63.6 vs. 57.1%, P =  0.605) and treat-
ment rate (42.4 vs. 32.1%, P  =  0.409) did not signifi-
cantly differ between the 2 groups. However, the FPG 
concentration was higher among subjects with a family 
history of diabetes (170.9 ±  73.9 vs. 140.3 ±  46.3  mg/
dL, P =  0.050), which suggests the poor diabetes con-
trol. The prevalence of diabetic retinopathy was also 
higher in subjects with a family history of diabetes, 
although the difference was not significant (18.2 vs. 
10.7%, P = 0.412).
Discussion
In the present study, we observed that the prevalence of 
type 2 diabetes and metabolic syndrome was greater in 
young Korean adults (aged 25–44  years) with a family 
history of diabetes, based on a nationwide representa-
tive survey. Moreover, young adults with a currently nor-
mal glucose tolerance, but has family history of diabetes, 
had higher FPG and triglyceride levels, which indicates 
a future risk of progression to type 2 diabetes and meta-
bolic disorders. In addition, the obesity-related parame-
ters, including BMI, WC, and triglyceride concentration, 
were significantly correlated with those of the parents. 
However, the risk-reducing behavior, including exercise 
and calorie intake, did not markedly differ according to 
the family history of diabetes.
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The family history of diabetes appears to be an inex-
pensive and promising health tool to estimate the pub-
lic metabolic risk, and is reportedly associated with 
adverse metabolic outcomes such as type 2 diabetes 
and atherosclerotic cardiovascular disease [11, 30–32]. 
The incidence of type 2 diabetes increased by 1.4- to 
6.1-fold in the cases with a family history of diabetes; 
the specific value differed according to study design, 
definition, and demographic characteristics [6]. Young 
adults aged  <45  years were enrolled in the present 
study, whereas previous studies primarily included 
middle-aged adults or those of all ages [9–11, 13–16]. 
The American Diabetes Association suggested that dia-
betes screening should begin at the age of 45 years, par-
ticularly among obese individuals [5]; however, young 
adults should also be considered for screening depend-
ing on the risk factors. We observed a higher preva-
lence of type 2 diabetes and metabolic syndrome, along 
with deteriorated metabolic profiles including FPG 
levels, triglyceride levels, and HOMA-β, even in young 
adults with good glucose tolerance but with a family 
history of diabetes. Notably, family history of diabe-
tes itself was associated with an increased BMI in our 
analysis. Hence, we explored the strong correlation of 
BMI, WC, and triglyceride concentration between par-
ents and their offspring. Young adults who are expected 
to have a higher risk of developing metabolic disorders 
(i.e. those with multiple family members with diabetes 
and those who are obese) should be considered for reg-
ular screening for diabetes even though they may cur-
rently have a normal metabolic profile.
Lifestyle modifications and close monitoring for diabe-
tes should be encouraged in subjects at risk of metabolic 
disorders. In the HealthStyles 2004 survey, the presence 
of a family history of diabetes was positively associated 
with risk awareness and risk-reducing behaviors in adults 
in the United States [10]. In contrast, Korean adults 
reported a lower perceived risk of developing diabetes 
as compared to Caucasians [33]. In the present study, 
no significant difference in the risk-reducing behavior, 
including exercise and diet, was observed in subjects with 
a family history of diabetes. Hence, healthcare provid-
ers should attempt to educate subjects with a family his-
tory of diabetes regarding the need for lifestyle changes 
and better awareness of the metabolic risk, particularly 
among ethnicities with a lower perceived risk.
Our study has several distinctive features. First, we 
included young adults aged <45 years who had a relatively 
lower risk of metabolic disorders and were neglected for 
diabetes screening based on the clinical guidelines. To 
our knowledge, this is one of the first studies to com-
prehensively assess the risk of metabolic disease and 
behavioral patterns particularly among young adults. We 
propose that the risk of type 2 diabetes and metabolic 
syndrome is greater among young adults (aged <45 years) 
with a family history of diabetes, and suggest that screen-
ing and lifestyle interventions are needed. Second, we 
included both parents and their progeny as a cluster, 
which facilitated the correlation analysis of various meta-
bolic parameters, in order to determine the inheritance 
of obesity.
Our study has several limitations. First, due to the 
cross-sectional nature of the study, we could not inves-
tigate the causal relationship or its underlying mecha-
nism. In addition, several confounding factors might 
have contributed to our results. For example, BMI was 
higher among subjects with a family history of diabetes, 
but these differences did not affect the main purpose of 
this study, as it suggests that a family history of diabetes 
itself is associated with an increased risk of obesity and 
its complications. In addition, we performed additional 
analyses, by stratifying for age and BMI, to control for 
these parameters. Second, recall bias might have con-
tributed to the results, as the questionnaires were self-
administered. Hence, we validated the family history 
collected by the questionnaire, and found that the accu-
racy was as high as 95.2%. Third, subjects with type 1 dia-
betes might have been included in the study population; 
nevertheless, we attempted to exclude these subjects by 
limiting the age range from 25 to 44 years.
Table 3 Correlation of metabolic profiles between parents 
and their offspring
Pearson’s correlation efficient between parents and their offspring are presented 
(n = 578). HOMA-IR and HOMA-β were log transformed for the analysis
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Conclusion
By assessing the nationwide survey data represent-
ing the Korean population, we found that a family his-
tory of diabetes was associated with an increased risk 
of metabolic disorders in young adults. Hence, young 
adults with diabetes risk factors, such as a family his-
tory of diabetes, should be considered for screening 
of diabetes and metabolic disorders. We advocate that 
family history assessment—an inexpensive but pre-
cious measure—should be included as a public health 
screening tool. Further studies should focus on defin-
ing specific criteria for diabetes screening, such as age 
range, test measure, and the interval to effectively and 
efficiently detect persons at risk.
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